Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Announces Proposed Public Offering Form 8 K
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
28/06/2024 | Press release | Distributed by Public on 29/06/2024 04:25
Item 3.03 Material Modification to Rights of Security Holders.
The information disclosed in Item 5.07 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03 to the extent required herein.
Please select the service you want to use:
Smartlinks | SDCL EDGE Acquisition Corporation | Company News | Shareholders | Shareholder Meeting | Proxy Statements | Investment Funds | Lifestyle and Leisure | Leisure | Shell Companies | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact